The following resources are available to the EPIGEN consortium..

Over 5000 epilepsy patients recruited from the following hospitals..

The Institute of Neurology, Queen Square, London, UK.

Beaumont Hospital, Dublin, Ireland.

Hopital Erasme, Universite Libre de Bruxelles, Belgium.

Duke University Hospital, Durham, North Carolina, USA.

Core genotyping facility

The EPIGEN consortium has access to Duke University Institute Genome Sciences and Policy high throughput genotyping facility. Availing of ABI taqman and Illumina Bead Array technology, this facility provides the EPIGEN consortium with genotyping for projects of all sizes.

Statistical support

Research conducted by the EPIGEN consortium can call on statistical support from Duke University IGSP, and the genetics programmes at RCSI and the ION.

back to top

"applying genomics to epilepsy therapeutics and predisposition"


Contact EPIGEN Home

About us Philosophy News Projects resources publications links	The following resources are available to the EPIGEN consortium.. Over 5000 epilepsy patients recruited from the following hospitals.. The Institute of Neurology, Queen Square, London, UK. Beaumont Hospital, Dublin, Ireland. Hopital Erasme, Universite Libre de Bruxelles, Belgium. Duke University Hospital, Durham, North Carolina, USA. Core genotyping facility The EPIGEN consortium has access to Duke University Institute Genome Sciences and Policy high throughput genotyping facility. Availing of ABI taqman and Illumina Bead Array technology, this facility provides the EPIGEN consortium with genotyping for projects of all sizes. Statistical support Research conducted by the EPIGEN consortium can call on statistical support from Duke University IGSP, and the genetics programmes at RCSI and the ION. back to top © Copyright 2008, The EPIGEN Consortium.	"applying genomics to epilepsy therapeutics and predisposition"